Editorial
doi: 10.1245/s10434-006-9024-x.
Epub 2006 Sep 3.
Selection of patients for resection of hepatic colorectal metastases: expert consensus statement by Charnsangavej et al
- PMID: 16952024
- DOI: 10.1245/s10434-006-9024-x
Item in Clipboard
Editorial
Selection of patients for resection of hepatic colorectal metastases: expert consensus statement by Charnsangavej et al
Ann Surg Oncol.
2006 Oct.
No abstract available
Comment on
-
Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.Ann Surg Oncol. 2006 Oct;13(10):1261-8. doi: 10.1245/s10434-006-9023-y. Epub 2006 Sep 1. Ann Surg Oncol. 2006. PMID: 16947009 No abstract available.
Similar articles
-
Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.Ann Surg Oncol. 2006 Oct;13(10):1261-8. doi: 10.1245/s10434-006-9023-y. Epub 2006 Sep 1. Ann Surg Oncol. 2006. PMID: 16947009 No abstract available.
-
Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al.Ann Surg Oncol. 2006 Oct;13(10):1281-3. doi: 10.1245/s10434-006-9149-y. Epub 2006 Sep 9. Ann Surg Oncol. 2006. PMID: 16964448 No abstract available.
-
Whole-body MRI added to gadoxetic acid-enhanced liver MRI for detection of extrahepatic disease in patients considered eligible for hepatic resection and/or local ablation of colorectal cancer liver metastases.Acta Radiol. 2020 Feb;61(2):156-167. doi: 10.1177/0284185119855184. Epub 2019 Jun 12. Acta Radiol. 2020. PMID: 31189329 No abstract available.
-
Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.J Surg Oncol. 2010 Dec 15;102(8):955-9. doi: 10.1002/jso.21729. J Surg Oncol. 2010. PMID: 21165998 Review.
-
Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.Radiographics. 2001 Oct;21 Spec No:S55-69. doi: 10.1148/radiographics.21.suppl_1.g01oc05s55. Radiographics. 2001. PMID: 11598248 Review.
Cited by
-
Improving the prediction of patient survival with the aid of residual convolutional neural network (ResNet) in colorectal cancer with unresectable liver metastases treated with bevacizumab-based chemotherapy.Cancer Imaging. 2024 Dec 18;24(1):165. doi: 10.1186/s40644-024-00809-1. Cancer Imaging. 2024. PMID: 39696483 Free PMC article.
-
Colorectal Liver Metastases: A Literature Review of Viable Surgical Options with a Special Focus on Microwave Liver Thermal Ablation and Mini-Invasive Approach.J Pers Med. 2022 Dec 23;13(1):33. doi: 10.3390/jpm13010033. J Pers Med. 2022. PMID: 36675694 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
